Status:
COMPLETED
Topical Cosmetic Products for Hand and Foot Syndrome
Lead Sponsor:
Dermophisiologique s.r.l
Collaborating Sponsors:
European Institute of Oncology
Conditions:
Hand Foot Skin Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to evaluate the efficacy of a dermocosmetic protocol in reducing the main cutaneous side effects that occur in palmar-plantar erythrodysesthesia syndrome in subjects with a tum...
Detailed Description
Cancer patients undergoing active oncological treatment (chemotherapy, biological therapies, radiotherapy) experience multiple side effects, including skin toxicity, which negatively affects their qua...
Eligibility Criteria
Inclusion
- Cancer diagnosis undergoing oncological therapy with chemotherapeutic agents, targeted therapy, immunotherapy hormonal treatments
- Patients with grade 1 of Hand-foot syndrome (HFS) Male and female patients 18 age or more
- Conditions favoring the correct execution of the proposed program
- Signature of informed consent, privacy and the form for the use of the data
Exclusion
- Pregnancy or breastfeeding in progress
- Other skin toxixities different from HFS
- Patients with HFS adverse skin symptoms higher than grade 1
- Psychic or other disorderes
- Patients with preexisting skin disorders thet could interfere with thw study results (like dermatitis, prosriais)
- Known hypersensitivity or allergy to one of the components of the products
Key Trial Info
Start Date :
August 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT06586073
Start Date
August 31 2022
End Date
November 30 2023
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
European Institute of Oncology (IEO)
Milan, Milan, Italy, 20141